Epoetin beta: all 40 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Predictors of Response to Iron and Erythropoietin Stimulating AgentsCompletedNCT03658876Phase 4Results posted
- A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With ChemotherapyCompletedNCT02767765Phase 3Results posted
- A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing ChemotherapyCompletedNCT02761642Phase 2Results posted
- Treatment Response in Dialysis AnaemiaCompletedNCT02707757Phase 4Results posted
- A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)CompletedNCT02145026Phase 4Results posted
- Effect of Erythropoietin (EPO) in Kidney After Cardiac SurgeryCompletedNCT00654992Phase 2/3Results posted
- A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.CompletedNCT00551291Phase 2Results posted
- (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic NephropathyCompletedNCT00354341Phase 3Results posted
- A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal AnemiaCompletedNCT00321919Phase 3Results posted
- A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on DialysisCompletedNCT02827266Phase 3
- A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid MalignancyTerminatedNCT02624141Phase 4
- A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin BTerminatedNCT02608060Phase 4
- A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal AnemiaCompletedNCT02569515Phase 4
- A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic MalignanciesCompletedNCT02564094Phase 4
- A Study of Epoetin Beta (NeoRecormon) in Participants With Solid TumorsCompletedNCT02554942Phase 4
- Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)CompletedNCT02428686Phase 2
- Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.CompletedNCT01718379Phase 2
- Prevention of Contrast Induced Nephropathy by ErythropoietinStatus unknownNCT01364402Phase 3
- Study of Erythropoietin (EPO) Administration ScheduleCompletedNCT01111630Phase 4
- Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male SubjectsCompletedNCT01085552Phase 1
- Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac SurgeryStatus unknownNCT01066351Phase 3
- Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)CompletedNCT01015352Phase 2
- Perioperative Iron With Erythropoietin in Bilateral Total Knee Replacement Arthroplasty (TKRA)CompletedNCT01012063Not applicable
- Epoetin Beta in Patients Undergoing Chemotherapy for Solid TumorsTerminatedNCT00875004Not applicable
- Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney TransplantCompletedNCT00815867Phase 3
- A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid MalignanciesCompletedNCT00776425Phase 4
- Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) PatientsCompletedNCT00628043Phase 3
- Erythropoietin Treatment in Extremely Low Birth Weight InfantsCompletedNCT00593801Not applicable
- Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid TumorsCompletedNCT00559195Phase 2
- Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With CancerStatus unknownNCT00482716Phase 3
- A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.TerminatedNCT00440063Phase 4
- A Study of NeoRecormon in Patients With Chronic Kidney Disease.CompletedNCT00437723Phase 4
- A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.CompletedNCT00413101Phase 4
- Correction of Anaemia and Progression of Renal Failure on Transplanted PatientsCompletedNCT00396435Phase 4
- COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.CompletedNCT00377481Phase 4
- Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPBCompletedNCT00273767Phase 2
- Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis CCompletedNCT00262379Phase 3
- PROTECT: Prospective Trial on Erythropoietin in Clinical TransplantationCompletedNCT00157300Phase 4
- Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.CompletedNCT00145652Phase 3
- Epoetin Beta in Treating Anemia in Patients With Cervical CancerCompletedNCT00046969Phase 4